Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Price:
28.36 NZD
-1.7%
Market Closed
Updated:
May 21, 2024
P/OCF
Price to OCF
Price to OCF
41.9
Current
36.2
Median
16
Industry
Higher
than median
Higher
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=41.9
Market Cap
/
16.5B
Operating Cash Flow
392.8m
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| NZ |
|
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
|
16.5B NZD | 41.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.5B USD | 25.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.5B USD | 82.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 36.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.2B USD | 17.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.7B USD | 45 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.3B USD | 18.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.8B EUR | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.3B USD | 60.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.9B USD | 64.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
369.4B CNY | 29.3 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
